Renault Tobacco petitions FDA for e-cigarette regulations

Feb.14.2023
Renault Tobacco petitions FDA for e-cigarette regulations
Reynolds Tobacco Company petitions FDA for stricter regulations on disposable e-cigarettes, citing potential health risks.

On February 6th, the parent company of Vuse, Reynolds American Inc., filed a citizen petition urging the US Food and Drug Administration (FDA) to establish mandatory regulations regarding the issue of illicit sales of disposable e-cigarette products.


On February 8th, the FDA released this information on Regulations.gov in order to solicit public comments.


Source of the image: Regulations.gov


Renova Tobacco stated in a petition, "As known by the FDA, users of electronic cigarette products in the United States have increasingly favored disposable options. A new policy specifically targeting these illegally marketed disposable electronic cigarette products is now needed to better protect public health.


Renovo Tobacco is requesting that the FDA prioritize the following areas for enforcement.


Any flavored disposable electronic cigarette (excluding tobacco or mint-flavored products); any disposable electronic cigarette containing nicotine from any source outside of tobacco that has not received pre-market authorization; any disposable electronic cigarette containing nicotine from tobacco that was not on the market as of August 8th, 2016, or for which the manufacturer did not submit a PMTA by September 9th, 2020, or did submit a PMTA but was denied and not challenged in court; any disposable electronic cigarette for which the manufacturer did not (or failed to) take adequate measures to prevent underage access; any disposable electronic cigarette marketed towards minors or that may promote use by minors.


It has been reported that RJ Reynolds Vapor Co. will no longer sell disposable e-cigarettes or other e-cigarette products with flavors other than tobacco or menthol. This decision follows the approval by the US Fifth Circuit Court of Appeals of the Food and Drug Administration's (FDA) marketing refusal order (MDO) for two RJ Reynolds Vapor Co. mint-flavored pods.


Renovo Tobacco stated in regards to its expected enforcement priorities that 'such policies will remedy existing loopholes in the FDA's current tobacco enforcement efforts, particularly concerning youth-related issues.'


Reference:


1. Citizen Petition.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13
Russian Vape GOST Revision Would Limit Capacity, Packaging Design and Warning Labels
Russian Vape GOST Revision Would Limit Capacity, Packaging Design and Warning Labels
Russia is preparing changes to its e-cigarette state standard GOST R 58109–2018. Under a draft order submitted to Rosstandart, the shelf life of vape devices and liquids would be limited to no more than two years, and capacity would be strictly capped at 2 mL for replaceable capsules, 10 mL for disposable systems and 30 mL for refill containers.
Apr.27 by 2FIRSTS.ai
Product | Dual-Chamber 20ml E-liquid and 35,000 Puffs: JNR ShishaSip 35K Goes on Sale Online in the Spanish and French Markets
Product | Dual-Chamber 20ml E-liquid and 35,000 Puffs: JNR ShishaSip 35K Goes on Sale Online in the Spanish and French Markets
E-cigarette brand JNR has recently launched its new pod-based device, the JNR ShishaSip 35K, on its official website. The product adopts a dual-chamber structure with two built-in 10ml prefilled pods, bringing total e-liquid capacity to 20ml. It is officially claimed to provide about 35,000 puffs and features a 1050mAh battery, a 0.6Ω mesh coil, a display screen, and adjustable airflow. The product is already on sale through online channels in France and Spain at a price of EUR 15.90.
Apr.10 by 2FIRSTS.ai
Special Report| War continues to shape the Ukrainian tobacco market
Special Report| War continues to shape the Ukrainian tobacco market
Four years into the war, Ukraine’s tobacco market is being reshaped by stress-driven consumption, tax pressure, youth e-cigarette use and a growing illicit segment. Surveys point to rising tobacco and nicotine product use, while higher excise duties and shadow trade are adding new complexity to the market.
Apr.17
Philip Morris Ukraine Says It Will Invest Another USD 10.00 Million in ZYN Nicotine Pouches This Year
Philip Morris Ukraine Says It Will Invest Another USD 10.00 Million in ZYN Nicotine Pouches This Year
Philip Morris said that after investing USD 5.00 million last year to promote its ZYN nicotine pouch brand in Ukraine, it plans to invest another USD 10.00 million this year to develop the nicotine pouch category and launch a new ZYN line.
Apr.08 by 2FIRSTS.ai
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Center for Tobacco Products Acting Director Bret Koplow issued a statement on May 7 outlining new steps to accelerate tobacco product premarket application review. The statement said CTP reduced the backlog of applications by approximately 70% in 2025 and that there is no longer a queue for PMTAs pending acceptance review.
May.09 by 2FIRSTS.ai